Concepts (239)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Repressor Proteins | 3 | 2015 | 2986 | 0.500 |
Why?
|
| Gene Regulatory Networks | 2 | 2015 | 1745 | 0.340 |
Why?
|
| Embryonic Stem Cells | 2 | 2015 | 1263 | 0.310 |
Why?
|
| Genetic Diseases, X-Linked | 2 | 2021 | 386 | 0.290 |
Why?
|
| Histones | 5 | 2023 | 2580 | 0.280 |
Why?
|
| De Lange Syndrome | 1 | 2024 | 21 | 0.230 |
Why?
|
| Meningocele | 1 | 2024 | 47 | 0.230 |
Why?
|
| Lens, Crystalline | 2 | 2015 | 389 | 0.210 |
Why?
|
| Chromosomes, Human, Pair 15 | 1 | 2024 | 361 | 0.210 |
Why?
|
| Epilepsy | 3 | 2023 | 3290 | 0.210 |
Why?
|
| Seizures, Febrile | 1 | 2023 | 108 | 0.200 |
Why?
|
| Fragile X Syndrome | 1 | 2023 | 116 | 0.200 |
Why?
|
| Spinal Dysraphism | 1 | 2024 | 178 | 0.190 |
Why?
|
| Liver Failure | 1 | 2024 | 250 | 0.190 |
Why?
|
| Septins | 1 | 2021 | 49 | 0.190 |
Why?
|
| Neural Tube Defects | 1 | 2024 | 255 | 0.190 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2014 | 4369 | 0.190 |
Why?
|
| Basophils | 1 | 2024 | 407 | 0.190 |
Why?
|
| 5-Aminolevulinate Synthetase | 1 | 2021 | 64 | 0.190 |
Why?
|
| Anemia, Sideroblastic | 1 | 2021 | 109 | 0.180 |
Why?
|
| Gene Expression Regulation | 3 | 2021 | 11903 | 0.170 |
Why?
|
| Chromatin Immunoprecipitation | 4 | 2017 | 855 | 0.170 |
Why?
|
| STAT3 Transcription Factor | 1 | 2024 | 871 | 0.170 |
Why?
|
| Intestinal Diseases | 1 | 2024 | 504 | 0.160 |
Why?
|
| Interleukins | 1 | 2024 | 782 | 0.160 |
Why?
|
| Neurons | 3 | 2024 | 9463 | 0.160 |
Why?
|
| Chromatin | 5 | 2024 | 2960 | 0.160 |
Why?
|
| Neurogenesis | 2 | 2015 | 863 | 0.160 |
Why?
|
| Genomics | 1 | 2014 | 5821 | 0.150 |
Why?
|
| DNA Copy Number Variations | 2 | 2024 | 2020 | 0.150 |
Why?
|
| Interleukin-17 | 1 | 2024 | 912 | 0.150 |
Why?
|
| Deafness | 1 | 2021 | 459 | 0.140 |
Why?
|
| Adipocytes | 1 | 2024 | 1194 | 0.140 |
Why?
|
| Cerebral Palsy | 1 | 2022 | 474 | 0.140 |
Why?
|
| Anemia, Iron-Deficiency | 1 | 2021 | 369 | 0.140 |
Why?
|
| Organoids | 1 | 2022 | 740 | 0.130 |
Why?
|
| Neutropenia | 1 | 2021 | 885 | 0.130 |
Why?
|
| Systemic Inflammatory Response Syndrome | 1 | 2021 | 621 | 0.130 |
Why?
|
| Crystallins | 1 | 2015 | 75 | 0.130 |
Why?
|
| Receptors, Glucocorticoid | 1 | 2017 | 305 | 0.130 |
Why?
|
| Liver Diseases | 1 | 2024 | 1298 | 0.120 |
Why?
|
| Leukemia, Biphenotypic, Acute | 1 | 2014 | 32 | 0.120 |
Why?
|
| Autistic Disorder | 1 | 2024 | 1220 | 0.120 |
Why?
|
| Paired Box Transcription Factors | 1 | 2015 | 206 | 0.120 |
Why?
|
| Conserved Sequence | 2 | 2015 | 1163 | 0.120 |
Why?
|
| Dermatitis, Atopic | 1 | 2022 | 731 | 0.120 |
Why?
|
| Disease Susceptibility | 1 | 2021 | 1787 | 0.120 |
Why?
|
| SOX9 Transcription Factor | 1 | 2015 | 145 | 0.120 |
Why?
|
| Hearing Loss | 1 | 2021 | 783 | 0.120 |
Why?
|
| Pseudogenes | 1 | 2014 | 104 | 0.120 |
Why?
|
| Neovascularization, Pathologic | 1 | 2024 | 2645 | 0.110 |
Why?
|
| Prosencephalon | 1 | 2015 | 305 | 0.110 |
Why?
|
| Germ-Line Mutation | 1 | 2021 | 1858 | 0.110 |
Why?
|
| Hair Follicle | 1 | 2015 | 211 | 0.110 |
Why?
|
| Adult Stem Cells | 1 | 2015 | 221 | 0.100 |
Why?
|
| Arginine | 1 | 2016 | 934 | 0.100 |
Why?
|
| Proto-Oncogene Proteins c-ets | 1 | 2013 | 314 | 0.100 |
Why?
|
| Cell Movement | 1 | 2024 | 5203 | 0.100 |
Why?
|
| Placenta | 1 | 2021 | 1709 | 0.100 |
Why?
|
| Mice | 13 | 2024 | 81525 | 0.100 |
Why?
|
| Eye Proteins | 1 | 2015 | 633 | 0.100 |
Why?
|
| Enhancer Elements, Genetic | 2 | 2015 | 1363 | 0.100 |
Why?
|
| Myelodysplastic Syndromes | 1 | 2021 | 1394 | 0.100 |
Why?
|
| Lysine | 2 | 2013 | 993 | 0.100 |
Why?
|
| RNA Polymerase II | 1 | 2015 | 539 | 0.090 |
Why?
|
| Receptors, Androgen | 2 | 2017 | 1079 | 0.090 |
Why?
|
| Proteome | 1 | 2021 | 1862 | 0.090 |
Why?
|
| Epithelial Cells | 1 | 2022 | 3673 | 0.090 |
Why?
|
| RNA, Untranslated | 1 | 2014 | 459 | 0.090 |
Why?
|
| Crohn Disease | 1 | 2022 | 2279 | 0.080 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2022 | 17904 | 0.080 |
Why?
|
| Binding Sites | 2 | 2015 | 6055 | 0.080 |
Why?
|
| Schizophrenia | 2 | 2023 | 6937 | 0.080 |
Why?
|
| Transcription Factors | 5 | 2015 | 12128 | 0.080 |
Why?
|
| Genes | 1 | 2013 | 1823 | 0.080 |
Why?
|
| Homeodomain Proteins | 2 | 2016 | 2416 | 0.080 |
Why?
|
| Androgen Antagonists | 1 | 2017 | 1410 | 0.080 |
Why?
|
| Cell Proliferation | 1 | 2024 | 10445 | 0.080 |
Why?
|
| Adaptation, Physiological | 1 | 2015 | 1301 | 0.080 |
Why?
|
| Animals | 14 | 2024 | 168459 | 0.070 |
Why?
|
| Psychotic Disorders | 1 | 2023 | 3223 | 0.070 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 2022 | 2422 | 0.070 |
Why?
|
| Gene Silencing | 1 | 2014 | 1509 | 0.070 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2013 | 1115 | 0.070 |
Why?
|
| Autophagy | 1 | 2015 | 1326 | 0.070 |
Why?
|
| Base Sequence | 2 | 2015 | 12441 | 0.070 |
Why?
|
| Pregnancy Complications | 1 | 2021 | 2947 | 0.070 |
Why?
|
| Genome | 1 | 2015 | 1740 | 0.070 |
Why?
|
| Cell Lineage | 1 | 2015 | 2555 | 0.060 |
Why?
|
| Humans | 27 | 2024 | 761504 | 0.060 |
Why?
|
| Cell Line | 2 | 2021 | 15601 | 0.060 |
Why?
|
| Obesity | 2 | 2024 | 12947 | 0.060 |
Why?
|
| Nerve Tissue Proteins | 2 | 2015 | 4414 | 0.060 |
Why?
|
| Cell Differentiation | 4 | 2015 | 11528 | 0.060 |
Why?
|
| Oncogene Proteins | 2 | 2023 | 718 | 0.060 |
Why?
|
| Water Loss, Insensible | 1 | 2024 | 12 | 0.060 |
Why?
|
| Chromosome Duplication | 1 | 2024 | 75 | 0.060 |
Why?
|
| DNA Methylation | 2 | 2016 | 4398 | 0.060 |
Why?
|
| Child | 8 | 2024 | 80153 | 0.060 |
Why?
|
| Amyotrophic Lateral Sclerosis | 1 | 2015 | 1469 | 0.060 |
Why?
|
| Age of Onset | 2 | 2022 | 3305 | 0.060 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2015 | 3612 | 0.060 |
Why?
|
| Oxidative Stress | 1 | 2015 | 3113 | 0.060 |
Why?
|
| Chondroitin Sulfate Proteoglycans | 1 | 2024 | 141 | 0.060 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2013 | 2825 | 0.050 |
Why?
|
| Cell Line, Tumor | 4 | 2024 | 16981 | 0.050 |
Why?
|
| Stem Cells | 1 | 2016 | 3522 | 0.050 |
Why?
|
| Microarray Analysis | 2 | 2020 | 749 | 0.050 |
Why?
|
| Trisomy | 1 | 2024 | 260 | 0.050 |
Why?
|
| Cohort Studies | 5 | 2023 | 41487 | 0.050 |
Why?
|
| Prostatic Neoplasms | 2 | 2017 | 11118 | 0.050 |
Why?
|
| Chromosome Aberrations | 2 | 2024 | 1768 | 0.050 |
Why?
|
| Fragile X Mental Retardation Protein | 1 | 2023 | 116 | 0.050 |
Why?
|
| Ontario | 1 | 2023 | 398 | 0.050 |
Why?
|
| Phenotype | 4 | 2024 | 16591 | 0.050 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2017 | 5305 | 0.050 |
Why?
|
| Tremor | 1 | 2023 | 191 | 0.050 |
Why?
|
| Tetraploidy | 1 | 2021 | 28 | 0.050 |
Why?
|
| Bangladesh | 1 | 2024 | 736 | 0.050 |
Why?
|
| Nonheme Iron Proteins | 1 | 2021 | 9 | 0.050 |
Why?
|
| Trinucleotide Repeat Expansion | 1 | 2023 | 247 | 0.050 |
Why?
|
| Neutrophil Infiltration | 1 | 2024 | 390 | 0.050 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2017 | 8547 | 0.050 |
Why?
|
| Epidermis | 1 | 2024 | 528 | 0.050 |
Why?
|
| Genome, Human | 1 | 2014 | 4425 | 0.050 |
Why?
|
| Ataxia | 1 | 2023 | 306 | 0.050 |
Why?
|
| Brain | 2 | 2024 | 27112 | 0.040 |
Why?
|
| Leukemia, Myeloid, Acute | 1 | 2016 | 3613 | 0.040 |
Why?
|
| Ovalbumin | 1 | 2022 | 677 | 0.040 |
Why?
|
| Transcription, Genetic | 3 | 2023 | 7594 | 0.040 |
Why?
|
| Mice, Inbred BALB C | 2 | 2022 | 6216 | 0.040 |
Why?
|
| Disease Models, Animal | 4 | 2024 | 18252 | 0.040 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2011 | 1860 | 0.040 |
Why?
|
| Skin | 2 | 2024 | 4484 | 0.040 |
Why?
|
| Mice, Knockout | 3 | 2024 | 14414 | 0.040 |
Why?
|
| Estrogen Receptor alpha | 1 | 2023 | 582 | 0.040 |
Why?
|
| Chromosomal Proteins, Non-Histone | 1 | 2024 | 727 | 0.040 |
Why?
|
| Female | 12 | 2024 | 392644 | 0.040 |
Why?
|
| Genetic Testing | 2 | 2023 | 3537 | 0.040 |
Why?
|
| MicroRNAs | 1 | 2014 | 3816 | 0.040 |
Why?
|
| Chromosomes, Human | 1 | 2020 | 441 | 0.040 |
Why?
|
| Epilepsy, Generalized | 1 | 2020 | 178 | 0.040 |
Why?
|
| RNA, Messenger | 3 | 2021 | 12795 | 0.040 |
Why?
|
| Heterozygote | 1 | 2024 | 2787 | 0.030 |
Why?
|
| Sequence Analysis | 1 | 2017 | 240 | 0.030 |
Why?
|
| Breast Neoplasms | 1 | 2024 | 21012 | 0.030 |
Why?
|
| RNA Splicing | 1 | 2021 | 918 | 0.030 |
Why?
|
| Th2 Cells | 1 | 2022 | 1060 | 0.030 |
Why?
|
| Menopause | 1 | 2024 | 1646 | 0.030 |
Why?
|
| Neoplasm Invasiveness | 1 | 2024 | 3595 | 0.030 |
Why?
|
| Estrogens | 1 | 2023 | 1522 | 0.030 |
Why?
|
| Phenylthiohydantoin | 1 | 2017 | 205 | 0.030 |
Why?
|
| Estradiol | 1 | 2023 | 1937 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2024 | 2455 | 0.030 |
Why?
|
| Azepines | 1 | 2017 | 329 | 0.030 |
Why?
|
| Male | 10 | 2024 | 360804 | 0.030 |
Why?
|
| Metabolism, Inborn Errors | 1 | 2017 | 284 | 0.030 |
Why?
|
| Astrocytes | 1 | 2023 | 1346 | 0.030 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2021 | 1651 | 0.030 |
Why?
|
| Interleukin-6 | 1 | 2024 | 3208 | 0.030 |
Why?
|
| Child, Preschool | 3 | 2022 | 42230 | 0.030 |
Why?
|
| Swine | 1 | 2024 | 5915 | 0.030 |
Why?
|
| Genes, ras | 1 | 2016 | 654 | 0.030 |
Why?
|
| Recovery of Function | 1 | 2024 | 2979 | 0.030 |
Why?
|
| Intestines | 1 | 2022 | 1909 | 0.030 |
Why?
|
| Methyltransferases | 1 | 2016 | 377 | 0.030 |
Why?
|
| Inflammation | 2 | 2024 | 10773 | 0.030 |
Why?
|
| Calorimetry | 1 | 2012 | 129 | 0.030 |
Why?
|
| Gene Expression Regulation, Leukemic | 1 | 2016 | 651 | 0.030 |
Why?
|
| Host-Pathogen Interactions | 1 | 2021 | 1459 | 0.030 |
Why?
|
| Iron | 1 | 2021 | 1793 | 0.030 |
Why?
|
| Feasibility Studies | 1 | 2023 | 5247 | 0.030 |
Why?
|
| Cell Cycle Proteins | 1 | 2024 | 3448 | 0.030 |
Why?
|
| Infant, Newborn | 2 | 2023 | 26198 | 0.030 |
Why?
|
| Nitriles | 1 | 2017 | 971 | 0.030 |
Why?
|
| Genetic Complementation Test | 1 | 2012 | 554 | 0.020 |
Why?
|
| Mutation | 3 | 2024 | 30052 | 0.020 |
Why?
|
| Triazoles | 1 | 2017 | 903 | 0.020 |
Why?
|
| Chromosomes, Human, 21-22 and Y | 1 | 2011 | 45 | 0.020 |
Why?
|
| Protein Binding | 2 | 2015 | 9351 | 0.020 |
Why?
|
| Benzamides | 1 | 2017 | 1370 | 0.020 |
Why?
|
| Signal Transduction | 3 | 2024 | 23445 | 0.020 |
Why?
|
| Antineoplastic Agents | 1 | 2014 | 13639 | 0.020 |
Why?
|
| Cells, Cultured | 2 | 2021 | 18965 | 0.020 |
Why?
|
| Stem Cell Niche | 1 | 2015 | 345 | 0.020 |
Why?
|
| Calcium Channels | 1 | 2015 | 620 | 0.020 |
Why?
|
| Immunoblotting | 1 | 2014 | 1646 | 0.020 |
Why?
|
| Thermodynamics | 1 | 2012 | 595 | 0.020 |
Why?
|
| Tumor Microenvironment | 1 | 2024 | 3877 | 0.020 |
Why?
|
| Neoplasms, Experimental | 1 | 2016 | 1229 | 0.020 |
Why?
|
| Brain Diseases | 1 | 2020 | 1545 | 0.020 |
Why?
|
| Seizures | 1 | 2023 | 2957 | 0.020 |
Why?
|
| Amino Acid Motifs | 1 | 2012 | 931 | 0.020 |
Why?
|
| Principal Component Analysis | 1 | 2013 | 943 | 0.020 |
Why?
|
| Organ Specificity | 1 | 2015 | 1967 | 0.020 |
Why?
|
| Pilot Projects | 1 | 2023 | 8631 | 0.020 |
Why?
|
| Methylation | 1 | 2012 | 1084 | 0.020 |
Why?
|
| Hemoglobins | 1 | 2015 | 1525 | 0.020 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2021 | 3639 | 0.020 |
Why?
|
| Endothelial Cells | 1 | 2022 | 3548 | 0.020 |
Why?
|
| Adolescent | 3 | 2023 | 88319 | 0.020 |
Why?
|
| Patch-Clamp Techniques | 1 | 2011 | 927 | 0.020 |
Why?
|
| Tumor Cells, Cultured | 1 | 2016 | 6132 | 0.020 |
Why?
|
| Nerve Growth Factors | 1 | 2011 | 564 | 0.020 |
Why?
|
| Mass Spectrometry | 1 | 2014 | 2192 | 0.020 |
Why?
|
| Structure-Activity Relationship | 1 | 2012 | 3076 | 0.020 |
Why?
|
| Protein Transport | 1 | 2012 | 1967 | 0.020 |
Why?
|
| Chromosome Deletion | 1 | 2011 | 1386 | 0.020 |
Why?
|
| Cytokines | 1 | 2021 | 7396 | 0.020 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2014 | 3778 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2024 | 22176 | 0.020 |
Why?
|
| Pluripotent Stem Cells | 1 | 2012 | 799 | 0.020 |
Why?
|
| DNA-Binding Proteins | 2 | 2013 | 9606 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 1 | 2024 | 22169 | 0.020 |
Why?
|
| Prostate | 1 | 2013 | 1770 | 0.020 |
Why?
|
| Promoter Regions, Genetic | 1 | 2016 | 5789 | 0.020 |
Why?
|
| Genetic Variation | 1 | 2020 | 6567 | 0.010 |
Why?
|
| Neoplasm Proteins | 1 | 2016 | 3617 | 0.010 |
Why?
|
| Enzyme Inhibitors | 1 | 2014 | 3712 | 0.010 |
Why?
|
| Cell Nucleus | 1 | 2012 | 2909 | 0.010 |
Why?
|
| Action Potentials | 1 | 2011 | 1834 | 0.010 |
Why?
|
| Hospitalization | 1 | 2023 | 10723 | 0.010 |
Why?
|
| Genetic Loci | 1 | 2012 | 2632 | 0.010 |
Why?
|
| Epigenesis, Genetic | 1 | 2016 | 3802 | 0.010 |
Why?
|
| Gene Expression | 1 | 2015 | 7581 | 0.010 |
Why?
|
| Models, Molecular | 1 | 2012 | 5439 | 0.010 |
Why?
|
| DNA | 1 | 2015 | 7212 | 0.010 |
Why?
|
| Peptides | 1 | 2012 | 4358 | 0.010 |
Why?
|
| Gene Expression Profiling | 1 | 2016 | 9420 | 0.010 |
Why?
|
| Adult | 3 | 2023 | 221177 | 0.010 |
Why?
|
| Carrier Proteins | 1 | 2012 | 4936 | 0.010 |
Why?
|
| Young Adult | 2 | 2020 | 59243 | 0.010 |
Why?
|
| Computational Biology | 1 | 2011 | 3518 | 0.010 |
Why?
|
| Pregnancy | 1 | 2021 | 29874 | 0.010 |
Why?
|
| Nuclear Proteins | 1 | 2012 | 5796 | 0.010 |
Why?
|
| Infant | 1 | 2020 | 36192 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2023 | 80636 | 0.010 |
Why?
|
| Time Factors | 1 | 2015 | 39967 | 0.010 |
Why?
|
| Middle Aged | 1 | 2011 | 220895 | 0.000 |
Why?
|
Concepts
(239)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(112)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_